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Meningococcus this winter: what was going on? 
D_ Falzon 
ABSTRACT: There was a time in the not very distant past when meningococcus was not being 
recognised locally. While laboratory sensitivity used to isolate Neisseria meningitidis has not 
changed in Malta, the frequency of its detection has increased, more so in the last few months_ 
In this discussion, it is assumed that the sensitivity of detection and degree of reporting of the 
condition has remained stable throughout the past eleven year period, so that the observed trend 
remains interpretable. Early, aggressive treatment with antimicrobials makes subsequent 
microbiological ascertainment difficult. Although meningococcal disease is notifiable by law, it is 
assumed that reporting of the recognised condition may not be full. 
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Introduction 
Although meningococcal disease is notifiable by law l , 
it is assumed that reporting of the recognised condition 
may not be full . In countries like Malta where 
meningococcal meningitis is usually sporadic, no 
epidemic threshold is defined, and disease is assumed to 
reach epidemic proportions when2: 
1. 	 occurrence increases three to fourfold compared 
to previous years 
2. 	 incidence of meningitis cases doubles from one 

week to the next for 3 consecutive weeks 

3. frequency in over 5 year olds rises as a proportion 
of all cases 
While laboratory sensitIvity used to isolate Neisseria 
meningitidis has not changed in Malta3, the frequency of 
its detection has increased, more so in the last few 
months. For the period October 1995-March 1996, eight 
confimled cases were registered, as against none for the 
corresponding period of the previous season (October 
1994-March 1995). With an expected yearly incidence 
of 1.91 (SO 1.22), it was evident that 7 cases of 
meningococcal disease in the first three months of 1996 
was abnomlal. 
Table 1 presents a simple time series for yearly 
incidence of verified disease episodes from 19854 . 
Averaging the incidence of bacterial meningitis (total) 
for 1985-95 gives an expected occurrence of 0.09 cases 
per week. If one were to consider the period 7-27 
March 1996, the actual occurrence for each 7 -day period 
would be as in Table 2. 
Table 2 - Weekly incidence of meningitis, 
Malta, 7-27 March 1996. 
Period 
March,1996 
Days 7 - 13 
Days 14 - 20 
Days 21 - 27 
Incident cases 
(bacterial meningitis) 
o 
5 
While it is established that the highest age-specific 
attack rates of invasive disease occur in infants5, none of 
the 7 cases for Feb-Apr 1996 were infants (age range 2­
26y, average age 13.7 years). This shift in age 
predilection has characterised reported outbreaks 
elsewhere6. Furthermore, two of these patients grew 
serogroup C organisms, while the same serogroup could 
not be excluded in the other 5. Another serogroup C 
case (F, 5 months) occurred with onset 7 December 
1995. As current knowledge indicates that epidemics 
are clonaI7, 'the last case noted till end-April (onset 23 
April) could not have been linked to the others, having 
been due to Neisseria meningitidis serogroup B. 
These indices suggest that the cases occurring in 
March were related in time and possibly in place (the 
whole of densely-populated Malta). A definite common 
link by person could not be established between any two 
Table 1 - Yearly crude incidence of meningococcal disease (meningitis &/or septicaemia), Malta, 1985 - Apr 1996. 
Year 85 86 87 88 89 90 91 92 93 94 95 96 
to Apr 
N mellillgilidis 
disease 
2 0 2 2 2 0 3 2 3 4 7 
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of the cases, but given the ease and extent of human 
mobility country wide this cannot be easily excluded. 
VVhathaschanged? 
N meningitidis is transmitted by respiratory droplets 
and does not survive long outside the human body. At 
anyone time, some 10% of the general population may 
be nasopharyngeal carriers, mostly having non-virulent 
strains. Carriage is higher in young adults, in smokers 
and in overcrowded settings. While carriage may last 9 
months, invasion develops within a week of acquisition 
(incubation 2-10 days)8. 
Predisposing factors to invasive disease include: 
Host factors: age, immunity status, respiratory 
tract infections 
Agent factors: virulence 
Environmental factors: dryness, dust, cold 
There has been anecdotal evidence of successive 
waves of URTIs this winter in Malta. Influenza type A 
activity has been documented at the start of 19969. 
There is also evidence of another flu-like outbreak in 
late February this yearlO. These infections may have 
predisposed subjects to subsequent invasive-type illness 
with N. meningitidis. Climatic conditions may also 
26 
-;;~ 
Cl.E 
"=
"F­-~---­ -_ .0.. 0 _. ~- - -:. ­..: ­ .:;.-­ : -.----- ::. 10 .r --.­ ~--.--. 
~ 
wI­ - -- ~--
ttt t t 
9 '8 /96 10 /2 8 /96 12/1 7 /96 2 /6/96 3 /26 /96 6116 /96 
Date 
So urce : Meteorological Office, Luqa. April 1996 
Fig 1. - Ambient temperature, Malta Minimum 
Temperatures, period Oct 95-Mar 96. 
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Fig. 2 - Relative humidities, Malta Minimum 
Humidity, period Oct 95-Mar 96. 
have favoured epidemic transmission. An epidemic of 
meningococcal meningitis (serogroup A) was raging 
concurrently in the African meningitis belt, causing 
38,000 cases and 5,000 deaths l !. Fig. 1 and Fig. 2 
depict the local variations in minimal relative humidity 
and an1bient temperatures for the period of interest. 
Dips in temperature and humidity coincide with 
clustering of reported illness (as indicated on the x-axis). 
Table 3 shows the demographic and microbiological 
characteristics of the cases for the period November 
1995 to April 1996. The distribution by residence 
indicates country wide involvement. 
Table 3 - Bacterial meningitis, Malta (Nov 95 - Apr 96)* 
Sex Age Residence Onset Isolate 
M 16y B'kara 16/11/95 GrpB 
F 20y Zurrieq 26/11/95 Not typed 
F 5m Zabbar 07/12/95 GrpC 
F 5y St Julians 16/02/96 Not typed 
M 19y St Julians 20/03/96 Not typed 
F 6w Fgura 21/03/96 G-ve rods 
F 21y Mellieha 21/03/96 Not typed 
F 2y Kirkop 21/03/96 GrpC 
M 26y Rabat 26/03/96 Bact men 
M 16y Swieqi 27/03/96 Bact men 
F 2y Marsa 29/03/96 GrpC 
M 21y Mtarfa 15/04/96 G-ve cocci 
F 26y Zurrieq 23/04/96 GrpB 
* excludes 1 case of Haemophilus intluenzae 
b meningitis in a F 18mo, onset 4 Jan 1996. 
Action indicated 
The mainstay of preventive action is identifying 
significant contacts, administering prophylactic 
antimicrobials and making them and their carers aware 
of the need to get early medical attention on suggestive 
symptoms. 
1. 	 Chemoprophylaxis 
Chemoprophylaxis is given to eliminate carriage, and 
hence reduce the risk of invasive disease in close 
contacts. It should be taken as soon as possible after 
diagnosis of the index case. 
The subjects for whom it is indicated are:5 
• 	 Index case/s, unless having eradicative dosage of 
ceftriaxone 
• Household contacts: anyone living in the index 
household during the 7 days before onset of illness. 
Family members of the index case are at a higher risk of 
developing disease than the general community (kindred 
genetic susceptibility and increased exposure), risk 
being highest in the first 7 days following infection. 
The type of contact indicating treatment is one close and 
prolonged, like persons sleeping in the same house, boy/ 
girlfriends and childminders in homes. 
It is therefore not indicated routinely following cheek 
kissing, or for health care workers unless they have been 
involved in mouth-to-mouth resuscitation, or handling 
infected secretions directly. During the management of 
the recent episodes of disease, ciprotloxacin has been 
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used for non-pregnant females, and should conceivably 
improve patient adherence given the stat d()sage. 
Rifampicin is being reserved for the young, and used as 
sparingly as possible given concerns about development 
of microbial resistance to the agent. A total of 235 (av 
33.6; range 5-69/case) contacts were prescribed 
prophylactic antibiotics by the Disease Surveillance 
Branch in connexion with the seven cases of 
meningococcal disease this year. An unestablished 
number of others (eg hospital staff, secondary contacts) 
had similar medication of their own accord or through 
their GP. Most of this would not have been justified but 
reflects a tendency to panic. 
2. 	 Vaccines 
There are two meningococcal vaccines on the market, 
Bivalent (A+C) and Quadrivalent (A,C,Y,W135). 
Antibodies form within 7-10 days after single-dose 
administration, and protection lasts for about 3 years. 
The local policy up to now (currently being revised) has 
been to vaccinate only persons travelling to areas with 
habitual epidemics (eg African meningitis belt)12. 
Immunisation is now being considered as an adjunct to 
chemoprophylaxis to avert extension, or help control an 
epidemic. In epidemic situations, early serogroup 
characterisation becomes important as a mass­
vaccination campaign may halt an epidemic 'due to a 
vaccine-sensitive strain within a few weeks2. 
3. 	 Information 
It is useful for contacts exposed, their carers and 
medical practitioners to maintain a high index of 
suspicion for early symptomatology and signs of 
meningococcal disease. An ad hoc leaflet in Maltese 
has been developed by the Department of Public Health, 
and is handed out to persons prescribed 
chemoprophylaxis. Physicians have been alerted to the 
increased occurrence of meningococcal disease through 
a joint clinical-public health meeting at the University of 
Malta Medical School (24 April), and a Departmental 
circular to GPs in Health Centres, Malta & Gozo (26 
April)13. 
Conclusions 
An increased occurrence of meningococcal disease 
was observed during last autumn and winter in persons 
resident In Malta. This article describes the pattern of 
disease and established contributory factors. Evidence 
presented suggests that occurrence of invasive 
meningococcal disease bordered on the epidemic 
proportion last season. Of a cluster of 4 cases with 
onset between 20 March and 15 April, two were 
confirmed as serogroup C while the same serogroup 
could not be excluded in the others. 
Ambient conditions around the dates of maximal 
incjdence may have been favourable for development of 
invasive disease (dips in relative humidity and minimal 
temperature). Influenza activity, which is known to 
predispose to meningococcal invasion, was also verified 
this winter. 
While the role of the weather-man in an early warning 
alert system stands to be defined, the case is made for 
closer cooperation between clinical, public health and 
hospital infection control sectors in this country to 
ensure implementation of timely measures to avert 
preventable extension of infection, and serious sequelae 
of the disease. 
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